Viking Clinical Site 148 — Philadelphia, Pennsylvania

Viking Clinical Site 148 is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Viking Clinical Site 148 has participated in 1 clinical trials.

Therapeutic areas: NASH - Nonalcoholic Steatohepatitis.

Sponsors: Viking Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Viking Clinical Site 148?

Viking Clinical Site 148 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Viking Clinical Site 148 conducted?

Viking Clinical Site 148 has 1 clinical trials on record. Their work covers NASH - Nonalcoholic Steatohepatitis.

Is Viking Clinical Site 148 accredited by Crixeo Health?

Viking Clinical Site 148 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Viking Clinical Site 148?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.